(MedPage Today) — The FDA gave the greenlight to use total hip bone mineral density (BMD) as a validated surrogate endpoint for clinical osteoporosis drug trials, the FDA announced on Friday.
A BMD test measures calcium and other bone minerals…
Source link : https://www.medpagetoday.com/endocrinology/osteoporosis/119140
Author :
Publish date : 2025-12-22 20:19:00
Copyright for syndicated content belongs to the linked Source.
